AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY
Authors: BLANEY SM NEEDLE MN GILLESPIE A SATO JK REAMAN GH BERG SL ADAMSON PC KRAILO MD BLEYER WA POPLACK DG BALIS FM
Citation: Sm. Blaney et al., PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY, Clinical cancer research, 4(2), 1998, pp. 357-360
PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY
Authors: BLANEY SM NEEDLE MN GILLESPIE A SATO JK REAMAN GH BERG SL ADAMSON PC KRAILO MD BLEYER WA POPLACK DG BALIS FM
Citation: Sm. Blaney et al., PHASE-II TRIAL OF TOPOTECAN ADMINISTERED AS A 72-HOUR CONTINUOUS-INFUSION IN CHILDREN WITH REFRACTORY SOLID TUMORS - A COLLABORATIVE PEDIATRIC BRANCH, NATIONAL-CANCER-INSTITUTE, AND CHILDRENS CANCER GROUP-STUDY, Clinical cancer research, 4(2), 1998, pp. 357-360
CONDUCT OF PHASE-I TRIALS IN CHILDREN WITH CANCER
Authors: SMITH M BERNSTEIN M BLEYER WA BORSI JD HO P LEWIS IJ PEARSON A PEIN F PRATT C REAMAN G RICCARDI R SEIBEL N TRUEWORTHY R UNGERLEIDER R VASSAL G VIETTI T
Citation: M. Smith et al., CONDUCT OF PHASE-I TRIALS IN CHILDREN WITH CANCER, Journal of clinical oncology, 16(3), 1998, pp. 966-978
A FLAT DOSE FOR ALL ADULT [SIC] PATIENTS
Authors: BLEYER WA
Citation: Wa. Bleyer, A FLAT DOSE FOR ALL ADULT [SIC] PATIENTS, Journal of clinical oncology, 16(11), 1998, pp. 3715-3715
METHOTREXATE-INDUCED LYMPHOMA
Authors: BLEYER WA
Citation: Wa. Bleyer, METHOTREXATE-INDUCED LYMPHOMA, Journal of rheumatology, 25(3), 1998, pp. 404-407
CHEMORADIOTHERAPY INTERACTIONS IN THE CENTRAL-NERVOUS-SYSTEM
Authors: BLEYER WA
Citation: Wa. Bleyer, CHEMORADIOTHERAPY INTERACTIONS IN THE CENTRAL-NERVOUS-SYSTEM, Medical and pediatric oncology, 1998, pp. 10-16
NEUROBLASTOMA SCREENING IN THE UNITED-STATES - RESULTS OF THE TEXAS OUTREACH PROGRAM FOR NEUROBLASTOMA SCREENING
Authors: ATER JL GARDNER KL FOXHALL LE THERRELL BL BLEYER WA
Citation: Jl. Ater et al., NEUROBLASTOMA SCREENING IN THE UNITED-STATES - RESULTS OF THE TEXAS OUTREACH PROGRAM FOR NEUROBLASTOMA SCREENING, Cancer, 82(8), 1998, pp. 1593-1602
TREATMENT OF PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA WITH BULKY EXTRAMEDULLARY DISEASE AND T-CELL PHENOTYPE OR OTHER POOR PROGNOSTIC FEATURES - RANDOMIZED CONTROLLED TRIAL FROM THE CHILDRENS CANCER GROUP
Authors: STEINHERZ PG GAYNON PS BRENEMAN JC CHERLOW JM GROSSMAN NJ KERSEY JH JOHNSTONE HS SATHER HN TRIGG ME UCKUN FM BLEYER WA
Citation: Pg. Steinherz et al., TREATMENT OF PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA WITH BULKY EXTRAMEDULLARY DISEASE AND T-CELL PHENOTYPE OR OTHER POOR PROGNOSTIC FEATURES - RANDOMIZED CONTROLLED TRIAL FROM THE CHILDRENS CANCER GROUP, Cancer, 82(3), 1998, pp. 600-612
PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL METHOTREXATE AND MERCAPTOPURINE IN CHILDREN WITH LOWER RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - A JOINT CHILDRENS CANCER GROUP AND PEDIATRIC ONCOLOGY BRANCH STUDY
Authors: BALIS FM HOLCENBERG JS POPLACK DG GE J SATHER HN MURPHY RF AMES MM WASKERWITZ MJ TUBERGEN DG ZIMM S GILCHRIST GS BLEYER WA
Citation: Fm. Balis et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL METHOTREXATE AND MERCAPTOPURINE IN CHILDREN WITH LOWER RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - A JOINT CHILDRENS CANCER GROUP AND PEDIATRIC ONCOLOGY BRANCH STUDY, Blood, 92(10), 1998, pp. 3569-3577
ACCUMULATION OF METHOTREXATE IN SYSTEMIC TISSUES AFTER INTRATHECAL ADMINISTRATION
Authors: BLEYER WA NELSON JA KAMEN BA
Citation: Wa. Bleyer et al., ACCUMULATION OF METHOTREXATE IN SYSTEMIC TISSUES AFTER INTRATHECAL ADMINISTRATION, Journal of pediatric hematology/oncology, 19(6), 1997, pp. 530-532
EQUAL PARTICIPATION OF MINORITY PATIENTS IN US NATIONAL PEDIATRIC CANCER CLINICAL-TRIALS
Authors: BLEYER WA TEJEDA HA MURPHY SB BRAWLEY OW SMITH MA UNGERLEIDER RS
Citation: Wa. Bleyer et al., EQUAL PARTICIPATION OF MINORITY PATIENTS IN US NATIONAL PEDIATRIC CANCER CLINICAL-TRIALS, Journal of pediatric hematology/oncology, 19(5), 1997, pp. 423-427
INFANT CANCER IN THE US - HISTOLOGY-SPECIFIC INCIDENCE AND TRENDS, 1973 TO 1992
Authors: GURNEY JG ROSS JA WALL DA BLEYER WA SEVERSON RK ROBISON LL
Citation: Jg. Gurney et al., INFANT CANCER IN THE US - HISTOLOGY-SPECIFIC INCIDENCE AND TRENDS, 1973 TO 1992, Journal of pediatric hematology/oncology, 19(5), 1997, pp. 428-432
NATIONAL CANCER CLINICAL-TRIALS - CHILDREN HAVE EQUAL ACCESS - ADOLESCENTS DO NOT
Authors: BLEYER WA TEJEDA H MURPHY SB ROBISON LL ROSS JA POLLOCK BH SEVERSON RK BRAWLEY OW SMITH MA UNGERLEIDER RS
Citation: Wa. Bleyer et al., NATIONAL CANCER CLINICAL-TRIALS - CHILDREN HAVE EQUAL ACCESS - ADOLESCENTS DO NOT, Journal of adolescent health, 21(6), 1997, pp. 366-373
THE US PEDIATRIC CANCER CLINICAL-TRIALS PROGRAMS - INTERNATIONAL IMPLICATIONS AND THE WAY FORWARD
Authors: BLEYER WA
Citation: Wa. Bleyer, THE US PEDIATRIC CANCER CLINICAL-TRIALS PROGRAMS - INTERNATIONAL IMPLICATIONS AND THE WAY FORWARD, European journal of cancer, 33(9), 1997, pp. 1439-1447
ACCIDENTAL INTRAMUSCULAR VINCRISTINE - LACK OF UNTOWARD EFFECTS AND RECOMMENDATIONS FOR MANAGEMENT
Authors: CLARK BS GALLEGOS E BLEYER WA
Citation: Bs. Clark et al., ACCIDENTAL INTRAMUSCULAR VINCRISTINE - LACK OF UNTOWARD EFFECTS AND RECOMMENDATIONS FOR MANAGEMENT, Medical and pediatric oncology, 28(4), 1997, pp. 314-315
THE SIGN OF LESER-TRELAT
Authors: HARDY RD DUVIC M BLEYER WA
Citation: Rd. Hardy et al., THE SIGN OF LESER-TRELAT, Medical and pediatric oncology, 28(3), 1997, pp. 234-237
GUIDELINES FOR THE PEDIATRIC CANCER CENTER AND ROLE OF SUCH CENTERS IN DIAGNOSIS AND TREATMENT
Authors: SANDERS J GLADER B CAIRO M FINKLESTEIN JZ FORMAN E GREEN D LUBAN N BLEYER WA LAMPKIN BC MURPHY SB WOODS WG
Citation: J. Sanders et al., GUIDELINES FOR THE PEDIATRIC CANCER CENTER AND ROLE OF SUCH CENTERS IN DIAGNOSIS AND TREATMENT, Pediatrics, 99(1), 1997, pp. 139-141
RECRUITING MINORITIES INTO CLINICAL-TRIALS - TOWARD A PARTICIPANT-FRIENDLY SYSTEM
Authors: BLEYER WA
Citation: Wa. Bleyer, RECRUITING MINORITIES INTO CLINICAL-TRIALS - TOWARD A PARTICIPANT-FRIENDLY SYSTEM, Journal of the National Cancer Institute, 88(6), 1996, pp. 377-377
INTRATHECAL LEUCOVORIN AFTER INTRATHECAL METHOTREXATE OVERDOSE
Authors: JARDINE LF INGRAM LC BLEYER WA
Citation: Lf. Jardine et al., INTRATHECAL LEUCOVORIN AFTER INTRATHECAL METHOTREXATE OVERDOSE, Journal of pediatric hematology/oncology, 18(3), 1996, pp. 302-304
CYTOREDUCTION AND PROGNOSIS IN ACUTE LYMPHOBLASTIC-LEUKEMIA - THE IMPORTANCE OF EARLY MARROW RESPONSE - REPORT FROM THE CHILDRENS CANCER GROUP
Authors: STEINHERZ PG GAYNON PS BRENEMAN JC CHERLOW JM GROSSMAN NJ KERSEY JH JOHNSTONE HS SATHER HN TRIGG ME CHAPPELL R HAMMOND D BLEYER WA
Citation: Pg. Steinherz et al., CYTOREDUCTION AND PROGNOSIS IN ACUTE LYMPHOBLASTIC-LEUKEMIA - THE IMPORTANCE OF EARLY MARROW RESPONSE - REPORT FROM THE CHILDRENS CANCER GROUP, Journal of clinical oncology, 14(2), 1996, pp. 389-398
CRANIOSPINAL IRRADIATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA WITH CENTRAL-NERVOUS-SYSTEM DISEASE AT DIAGNOSIS - A REPORT FROM THE CHILDRENS CANCER GROUP
Authors: CHERLOW JM SATHER H STEINHERZ P GAYNON P TUBERGEN D TRIGG M NOVAK L BLEYER WA
Citation: Jm. Cherlow et al., CRANIOSPINAL IRRADIATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA WITH CENTRAL-NERVOUS-SYSTEM DISEASE AT DIAGNOSIS - A REPORT FROM THE CHILDRENS CANCER GROUP, International journal of radiation oncology, biology, physics, 36(1), 1996, pp. 19-27
CHILDREN WITH CANCER
Authors: BLEYER WA
Citation: Wa. Bleyer, CHILDREN WITH CANCER, Gematologia i transfuziologia, 41(3), 1996, pp. 3-8
COMPARISON OF IDARUBICIN TO DAUNOMYCIN IN A RANDOMIZED MULTIDRUG TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA AT FIRST BONE-MARROW RELAPSE - A REPORT FROM THE CHILDRENS CANCER GROUP
Authors: FEIG SA AMES MM SATHER HN STEINHERZ L REID JM TRIGG M PENDERGRASS TW WARKENTIN P GERBER M LEONARD M BLEYER WA HARRIS RE
Citation: Sa. Feig et al., COMPARISON OF IDARUBICIN TO DAUNOMYCIN IN A RANDOMIZED MULTIDRUG TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA AT FIRST BONE-MARROW RELAPSE - A REPORT FROM THE CHILDRENS CANCER GROUP, Medical and pediatric oncology, 27(6), 1996, pp. 505-514
FUTURE-DEVELOPMENT OF AMIFOSTINE IN CANCER-TREATMENT
Authors: ALBERTS DS BLEYER WA
Citation: Ds. Alberts et Wa. Bleyer, FUTURE-DEVELOPMENT OF AMIFOSTINE IN CANCER-TREATMENT, Seminars in oncology, 23(4), 1996, pp. 90-99
USE OF MINORS AS BONE-MARROW DONORS - CURRENT ATTITUDE AND MANAGEMENT- A SURVEY OF 56 PEDIATRIC TRANSPLANTATION CENTERS
Authors: CHAN KW GAJEWSKI JL SUPKIS D PENTZ R CHAMPLIN R BLEYER WA
Citation: Kw. Chan et al., USE OF MINORS AS BONE-MARROW DONORS - CURRENT ATTITUDE AND MANAGEMENT- A SURVEY OF 56 PEDIATRIC TRANSPLANTATION CENTERS, The Journal of pediatrics, 128(5), 1996, pp. 644-648
Risultati: 1-25 | 26-38